Browsing: Longevity and Mortality Risk Transfer
Longevity and Mortality Investor’s coverage of the longevity and mortality risk transfer market, including pension risk transfer, longevity swaps and other de-risking activities.
Bodycote UK’s Pension Scheme has completed a £60m bulk purchase annuity buy-in with PIC. The transaction secures the benefits of all 680 scheme members.
€1.3bn longevity swap reinsurance agreement covers a portion of the defined benefit pensions included in a pension buy‑out and marks Pacific Life Re’s second longevity reinsurance transaction in the Netherlands.
The buy-in, covering both pensioners and deferred members, secures the benefits of over 3,600 members, while removing funding and investment risk for the scheme.
£113m bulk purchase annuity full buy-in secures the benefits of all 355 Section members within the scheme.
The deal secures the pension benefits of over 3,000 members of the Avon Cosmetics Pension Plan.
The deal secures the pension benefits of over 3,000 members of the Senior plc Pension Plan.
£240m transaction, completed in December 2025, protects the pensions of all of the remaining 1,852 scheme members whose policies were yet to be insured, including 924 pensioners and their dependants as well as a further 928 deferred members.
There is plenty of investment work still to do even for those US plan sponsors that are in the last mile of their buy-out journey.
The UK’s pension risk transfer market is poised for growth in 2026, with activity expected to surpass 2025 as larger schemes undertake more de-risking transactions, according to WTW’s annual De-risking report.
The transaction completed in January 2026 and secures the benefits of all pensioner and deferred members of the legacy defined benefit scheme. The deal is to be followed by an accelerated move to full buyout by April 2026.